5 mins
26 Mar 2026
Updated social media guidance: What pharmaceutical companies need to know
PMCPA has published revised and expanded guidance on the use of social media by pharmaceutical companies
More
Life sciences blog
Our life sciences law blog brings you up to date news and views on legal, regulation and policy decisions affecting the life science sector.
Results: 176 items
2 mins
23 Mar 2026
MHRA consultation: Permanent recognition of CE marked devices?
The MHRA is currently consulting on access for CE marked medical devices to the market in Great Britain (England, Scotland, and Wales) over the longer term.
More
2 mins
16 Feb 2026
Changes to branded medicines repayment rates under the Statutory Scheme
Two parallel schemes apply to control the costs of branded medicines to the NHS. These longstanding policy tools aim to ensure that the NHS can obtain the best possible value when purchasing medicines.
More
1 mins
21 Jan 2026
Tracking the UK’s medical devices reforms - the IVDs Roadmap
The MHRA has published an In Vitro Diagnostics Medical Devices Roadmap (IVDs Roadmap) as part of its wider Medical Devices Regulatory Reform Roadmap to implementation.
More
2 mins
15 Jan 2026
Public Order Act 2023: Infrastructure now classified as critical
In an interesting development for the life sciences sector, and which could therefore also have significance for the health and education sectors, the government announced in late November 2025 that it was laying a statutory instrument to include Life Sciences infrastructure as key national infrastructure for the purposes of the Public Order Act 2023.
More
2 mins
06 Jan 2026
Enhanced protection for life sciences infrastructure
The government is moving to classify life sciences infrastructure as key national infrastructure under the Public Order Act 2023, a change that may also impact the health and education sectors.
More
2 mins
05 Jan 2026
Regulating AI in healthcare: The UK government wants your input
The MHRA has launched its call for evidence on regulation of AI in healthcare. This particular call for evidence relates to AI used in medical devices (including standalone AI as a medical device).
More
4 mins
18 Dec 2025
Virtual Wards: Comparing the UK and EU Regulatory Landscape
Virtual wards and remote healthcare are reshaping the delivery of medical services. With the global telehealth market expected to reach $175.5 billion by 2026, both the UK and the EU are working to adapt their regulatory frameworks.
More
3 mins
16 Dec 2025
US/UK pharma and medtech deal – zero tariffs and enhanced UK spend
The recently announced US/UK trade deal on pharmaceuticals and medtech has been warmly welcomed by industry representatives, research institutes and medical research charities.
More
2 mins
03 Nov 2025
MHRA enforcement action on unlicensed weight-loss injections
UK medicines regulator, the MHRA, has carried out an extensive, two-day raid on an illicit weight loss medicines facility.
More
1 mins
16 Oct 2025
Precision bred varieties: What’s changing for plant breeders?
Legislation passed in 2023 opened the door to greater flexibility for precision genetic technology. From November 2025, new rules will streamline the approval process (in England only) for precision bred plant varieties—those developed using advanced gene editing tools like CRISPR, but without introducing foreign DNA.
More
7 mins
15 Oct 2025
PISCES: A new private stock market – implications for life sciences companies
PISCES is a new type of platform where shares in private companies can be traded. As companies choose to stay private for longer, PISCES should give investors the opportunity to trade private company shares easily and efficiently in an organised marketplace.
More